FDFarima Dalaei

Farima Dalaei

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farima Dalaei has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implant Plane Does Not Seem to Impact Shoulder Function after Direct-to-Implant Breast Reconstruction in Non-Radiated Patients: A Randomized Controlled Trial

    by Signe von Buchwald, Diana Lydia Dyrberg, Farima Dalaei, Jens Ahm Sørensen, Jørn Bo Thomsen

    Subpectoral implant placement in breast reconstruction has been associated with potential shoulder function impairment compared to prepectoral placement, though the evidence remains inconclusive. This study aimed to investigate differences in shoulder function following mastectomy and direct-to-implant breast reconstruction using prepectoral or subpectoral implant placement.Forty-two women aged 18 years or older, eligible for direct-to-implant breast reconstruction, were randomized 1:1 to undergo either prepectoral or subpectoral implant placement. Data were collected at baseline and at 3- and 12-month follow-ups. Shoulder function was assessed using the validated Constant Shoulder Score (CSS), which evaluates pain, activities of daily living, range of motion, and strength. Pectoralis major muscle (PMM) strength was also measured.Baseline and demographic characteristics were comparable between the groups. No differences were observed in total CSS or the modified CSS (including the PMM strength) between the prepectoral and subpectoral groups at baseline or at the 3- and 12-month follow-ups. At 12 months, total CSS (p = 0.74) and modified CSS (p = 0.45) remained similar across both groups.There were no significant differences in shoulder and arm function between the sub- and prepectoral reconstruction groups. These findings suggest that concerns regarding shoulder function should not dictate the choice of implant placement plane in direct-to-implant breast reconstruction.

  • Open Access

    The BODY-Q Belly Button Scale: A Development and Validation Study

    by Farima Dalaei, Claire E E de Vries, Charlene Rae, Trisia Breitkopf, Danny Mou, Maarten Hoogbergen, Jens Ahm Sørensen, Andrea L Pusic, Anne F Klassen

    Background: One of the critical steps in abdominoplasty or in reconstructive procedures involving abdominal tissue involves repositioning the belly button. However, there is limited knowledge about patient satisfaction regarding the appearance of the belly button after such procedures. Currently, there is no standardized patient-reported outcome measure designed to assess this outcome. Objectives: This study aimed to develop and validate a BODY-Q scale that measures patient satisfaction with the appearance of the belly button. Methods: In Phase 1 (qualitative), patient interview data were used to develop and refine the new BODY-Q scale. In Phase 2 (quantitative), the scale was field-tested through a crowdsourcing platform. Rasch measurement theory analysis was used for item reduction and to examine reliability and validity. Predefined hypotheses were tested by applying a 75% acceptance threshold, which was considered indicative of sufficient evidence for construct validity. Results: The BODY-Q Belly Button scale was refined through qualitative input from 5 patients. Psychometric validation was performed in a sample of 372 participants. Out of the 15 items assessed, 6 were retained in the final scale. This scale showed ordered thresholds, and the data fit the Rasch model (χ2 = 22.72, df = 24, P-value = .54). The scale evidenced reliability, with Person Separation Index and Cronbach α values ≥.81. For construct validity, acceptance of hypotheses was 89%. Conclusions: The BODY-Q Belly Button scale can be used in clinical practice and in research to assess satisfaction with the belly button from the patient's perspective. Level of Evidence: 4 (Risk): For image description, please refer to the figure legend and surrounding text.


  • Open Access

    Comparison of Patient-Reported Quality of Life Following Direct-to-Implant Prepectoral and Subpectoral Breast Reconstruction Using BREAST-Q: A Randomized Controlled Trial

    by Diana Lydia Dyrberg, Farima Dalaei, Martin Sollie, Camilla Bille, Vibeke Koudahl, Jens A Sørensen, Jørn Bo Thomsen

    Background Direct-to-implant breast reconstruction (DIR) is becoming more and more accepted. There is a lack of high-quality studies assessing differences in patient-reported quality of life (QoL) between different implant placement methods. The aim of this randomized controlled (clinical) trial was to compare QoL between women reconstructed by sub- or prepectoral implant placement. Methods We included women over 18 years eligible for DIR. Patients were randomly assigned to reconstruction by subpectoral or prepectoral implant placement. Assessment of QoL and patient satisfaction was made using the BREAST-Q questionnaire for postmastectomy breast reconstruction and compared between the sub- and prepectoral reconstructed groups preoperatively and after 3 and 12 months of follow-up. Results A total of 42 women were allocated to sub- or prepectoral reconstruction with 21 patients in each group. There were no differences in patient characteristics between groups. Regarding all the selected BREAST-Q scales: (1) satisfaction with the reconstructed breast, (2) satisfaction with the breast implant, (3) satisfaction with the overall outcome, (4) psychosocial well-being, (5) sexual well-being, and (6) physical well-being—we found no significant differences between the two groups. Assessing each group independently we found, that in both groups sexual well-being improved after surgery postoperatively compared to the preoperative scores. Conclusion We found high satisfaction and QoL following both sub- and prepectoral breast reconstruction. We found no significant differences between groups suggesting both methods for DIR can be used. Despite our high-quality data, a larger sample size and longer postoperative follow-up are needed to further investigate the differences in QoL between sub- and prepectoral breast reconstruction.


  • Open Access

    Improving the Impact of BODY-Q Scores Through Minimal Important Differences in Body Contouring Surgery: An International Prospective Cohort Study

    by Farima Dalaei, Phillip J Dijkhorst, Sören Möller, Anne F Klassen, Claire E E de Vries, Lotte Poulsen, Manraj N Kaur, Jørn Bo Thomsen, Maarten Hoogbergen, Sophocles H Voineskos, et al.

    The BODY-Q is a widely used patient-reported outcome measure for comprehensive assessment of treatment outcomes specific to patients undergoing body contouring surgery (BCS). However, for BODY-Q to be meaningfully interpreted and used in clinical practice, minimal important difference (MID) scores are needed. A MID is defined as the smallest change in outcome measure score that patients perceive important. The aim of this study was to determine BODY-Q MID estimates for patients undergoing BCS to enhance the interpretability of the BODY-Q. Data from an international, prospective cohort from Denmark, Finland, Germany, Italy, the Netherlands, and Poland were included. Two distribution-based methods were used to estimate MID: 0.2 standard deviations of mean baseline scores and the mean standardized response change of BODY-Q scores from baseline to 3 years postoperatively. A total of 12,554 assessments from 3,237 participants (mean age; 42.5±9.3 years; body mass index; 28.9±4.9 kg/m2) were included. Baseline MID scores ranged from 1 to 5 in the health-related quality of life (HRQL) scales and 3 to 6 in the appearance scales. The estimated MID scores from baseline to 3 years follow-up ranged from 4 to 5 in HRQL and from 4 to 8 in the appearance scales. The BODY-Q MID estimates from before BCS to 3 years postoperatively ranged from 4 to 8 and are recommended for use to interpret patients’ BODY-Q scores, evaluate treatment effects of different BCS procedures, and for calculating sample size for future studies.


  • Open Access

    Minimal important difference in weight loss following bariatric surgery: Enhancing BODY‐Q interpretability

    by Farima Dalaei, Phillip J. Dijkhorst, Sören Möller, Claire E. E. de Vries, Lotte Poulsen, Sophocles H. Voineskos, Manraj N. Kaur, Jørn Bo Thomsen, Ruben N. van Veen, Claus B. Juhl, et al.

    Summary: BODY‐Q is a patient‐reported outcome measure for comprehensive assessment of outcomes specific to patients undergoing bariatric surgery. The clinical utility of BODY‐Q is hampered by the lack of guidance on score interpretation. This study aimed to determine minimal important difference (MID) for assessment of BODY‐Q. Prospective BODY‐Q data from Denmark and the Netherlands pre‐ and post‐bariatric surgery were collected. Two distribution‐based methods were used to estimate MID by 0.2 standard deviations of baseline scores and the mean standardized response change of scores from baseline to 3‐years postoperatively. In total, 5476 assessments from 2253 participants were included of which 1628 (72.3%) underwent Roux‐en‐Y gastric bypass, 586 (26.0%) sleeve gastrectomy, 33 (1.5%) gastric banding, and 6 (0.03%) other surgeries. The mean age was 45.1 ± 10.9 with a mean BMI of 46.6 ± 9.6. Baseline MID ranged from 1 to 4 in health‐related quality of life (HRQL) and from 2 to 8 in appearance scales. The mean change of scores ranged from 4 to 5 in HRQL and from 4 to 7 in the appearance scales. The estimated MID for the change in BODY‐Q HRQL and appearance scales ranged from 3 to 8 and is recommended for use to interpret BODY‐Q scores and assess treatment effects in bariatric surgery.


  • Open Access

    Body Contouring Surgery After Bariatric Surgery Improves Long-Term Health-Related Quality of Life and Satisfaction With Appearance

    by Farima Dalaei, Claire E.E. de Vries, Lotte Poulsen, Sören Msc Möller, Manraj N. Kaur, Phillip J. Dijkhorst, Jørn Bo Thomsen, Maarten Hoogbergen, Dennis J.S. Makarawung, Aebele B. Mink van der Molen, et al.

    Objective: To examine health-related quality of life (HRQL) and satisfaction with appearance in patients who have undergone bariatric surgery (BS) with or without subsequent body contouring surgery (BCS) in relation to the general population normative for the BODY-Q. Background: The long-term impact of BS with or without BCS has not been established using rigorously developed and validated patient-reported outcome measures. The BODY-Q is a patient-reported outcome measure developed to measure changes in HRQL and satisfaction with appearance in patients with BS and BCS. Methods: Prospective BODY-Q data were collected from 6 European countries (Denmark, the Netherlands, Finland, Germany, Italy, and Poland) from June 2015 to February 2022 in a cohort of patients who underwent BS. Mixed-effects regression models were used to analyze changes in HRQL and appearance over time between patients who did and did not receive BCS and to examine the impact of patient-level covariates on outcomes. Results: This study included 24,604 assessments from 5620 patients. BS initially led to improved HRQL and appearance scores throughout the first postbariatric year, followed by a gradual decrease. Patients who underwent subsequent BCS after BS experienced a sustained improvement in HRQL and appearance or remained relatively stable for up to 10 years postoperatively. Conclusions: Patients who underwent BCS maintained an improvement in HRQL and satisfaction with appearance in contrast to patients who only underwent BS, who reported a decline in scores 1 to 2 years postoperatively. Our results emphasize the pivotal role that BCS plays in the completion of the weight loss trajectory.


  • Open Access

    BODY-Q Normative Scores: Psychometric Validation of the BODY-Q in the General Population in Europe and North America

    by Farima Dalaei, Claire E.E. de Vries, Stefan J. PhD Cano, Manraj N. Kaur, Lotte Poulsen, André Pfob, Danny Mou, Jussi P. Repo, Rosa Salzillo, Jakub Opyrchal, et al.

    Background: BODY-Q is a rigorously developed patient-reported outcome measure designed to measure outcomes of weight loss and body contouring patients. To allow interpretation and comparison of BODY-Q scores across studies, normative BODY-Q values were generated from the general population. The aim of this study was to examine the psychometric properties of BODY-Q in the normative population. Methods: Data were collected using two crowdsourcing platforms (Prolific and Amazon Mechanical Turk) in 12 European and North American countries. Rasch measurement theory (RMT) was used to examine reliability and validity of BODY-Q scales. Results: RMT analysis supported the psychometric properties of BODY-Q in the normative sample with ordered thresholds in all items and nonsignificant chi-square values for 167 of 176 items. Reliability was high with person separation index of greater than or equal to 0.70 in 20 of 22 scales and Cronbach alpha values of greater than or equal to 0.90 in 17 of 22 scales. Mean scale scores measuring appearance, health-related quality of life, and eating-related concerns scales varied as predicted across subgroups with higher scores reported by participants who were more satisfied with their weight. Analysis to explore differential item functioning by sample (normative versus field-test) flagged some potential issues, but subsequent comparison of adjusted and unadjusted person estimates provided evidence that the scoring algorithm worked equivalently for the normative sample as in the field-test samples. Conclusions: The BODY-Q scales showed acceptable reliability and validity in the normative sample. The normative values can be used as reference in research and clinical practice in combination with local estimates for parallel analysis and comparison.


  • Open Access

    Short term treatment of secondary lymphedema with hyaluronidase injections reduces mouse hindlimb lymphedema

    by Farima Dalaei, Amar Bucan, Alexander Wiinholt, Mads Gustaf Jørgensen, Christian Rønn Hansen, Christina Baun, Svend Hvidsten, Eva Kildall Hejbøl, Henrik Daa Schrøder, Jens Ahm Sørensen

    Lymphedema is a common complication following breast cancer treatment with axillary lymphadenectomy and radiotherapy. Currently, there is no curative treatment for this disease, hence there is a need for new therapeutic suggestions. The aim of this study was to investigate the effect of hyaluronidase (HYAL) injections after inducing hindlimb lymphedema in 36 female C57BL/6 mice. HYAL injections were administered every second day for 14 days in three groups: (1) HYAL for 1 week followed by saline for 1 week, (2) HYAL for 2 weeks, and (3) saline injections for 2 weeks. Volume of the lymphedema limb was weekly assessed with micro-computed tomography (μ-CT) scans for a total course of 6 weeks. Lymph vessel morphometry was assessed in the end of the study after staining cross-sections of the hindlimb for anti-LYVE-1 blindly. Lymphatic function was assessed by lymphoscintigraphy to assess lymphatic clearance. There was a significant reduction of the volume of lymphedema in mice treated with HYAL-7 compared with mice treated with HYAL-14 (p < 0.05) and saline (p < 0.05). No differences were detected in lymph vessel morphometry and the lymphoscintigraphy between groups. Short-term treatment with HYAL-7 might be a potential therapeutic suggestion for secondary lymphedema induced in mouse hindlimbs. In the future, clinical studies are needed to investigate the potential of HYAL treatment in human beings.


  • Predictors of improved psychological function after bariatric surgery

    by Phillip J. Dijkhorst, Dennis J.S. Makarawung, Joost W. Vanhommerig, Suzanne C. Kleipool, Farima Dalaei, Claire E.E. de Vries, Aebele B. van der Molen, Lotte Poulsen, Jens A. Sorensen, H. Jaap Bonjer, et al.


  • Open Access

    General population normative scores for interpreting the BODY‐Q

    by Farima Dalaei, Claire E. E. de Vries, Lotte Poulsen, Manraj N. Kaur, André Pfob, Danny Mou, Amalie L. Jacobsen, Jussi P. Repo, Rosa Salzillo, Jakub Opyrchal, et al.

    Summary: The BODY‐Q is a patient‐reported outcome measure used to assess outcomes in patients undergoing weight loss and/or body contouring surgery (BC) following massive weight loss. Normative values for the BODY‐Q are needed to improve data interpretation and enable comparison. Thus, the aim of this study was to determine normative values for the BODY‐Q. Participants were recruited internationally through two crowdsourcing platforms. The participants were invited to complete the BODY‐Q scales through an URL link provided within the crowdsourcing platforms. General linear analyses were performed to compare normative means between countries and continents adjusted for relevant covariates. Normative reference values were stratified by age, body mass index (BMI), and gender. The BODY‐Q was completed by 4051 (2052 North American and 1999 European) participants. The mean age was 36 years (±14.7 SD) and ranged from 17 to 76 years, the mean BMI was 26.4 (±6.7 SD) kg/m2, and the sample consisted of 1996 (49.3%) females and 2023 (49.9%) males. Younger age and higher BMI were negatively associated with all BODY‐Q scales (p < .001). This study provides normative values for the BODY‐Q scales to aid in the interpretation of BODY‐Q scores in research and clinical practise. These values enable us to understand the impact of weight loss and BC on patients' lives.